These studies identify critical target genes and alterations in these genes that may be important in chemical carcinogenesis. Mutation spectra in oncogenes (eg.- ras) and tumor suppressor genes (eg.- p53 and p16) from rodent tumors induced by certain carcinogens and from tumors of individuals exposed to environmental agents are being characterized in order to understand mechanisms of chemical carcinogenesis. In one study lung tumors from mice exposed to 2,2-bis-(bromomethyl)-1,3-propanediol (a fire retardant) are being examined for k-ras mutations and other alterations that will help define mechanisms. In another study lung tumors from patients exposed to asbestos are being examined for p53 mutations. Mutations are identified by single stranded conformation polymorphism analysis, restriction fragment length polymorphisms and direct sequencing following PCR amplification of gene fragments in DNA isolated from the tumors. In a study to identify murine lung tumor susceptibility genes that may have human homologs, our lab and others mapped a major lung tumor susceptibility locus to distal chromosome 6 in the region of k-ras, and evidence is accumulating that this susceptibility locus is k-ras. Other minor loci, which may represent modifying or enhancing genes, were mapped to chromosomes 9 and 19, and selective genotyping is being continued to map these loci more closely. In addition, sequences and activities of ras guanine nucleotide exchange factors (one of which maps to the region linked with susceptibility on chromosome 9) that may interact with activated ras are being studied to see if there are differences between resistant and susceptible strains.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Intramural Research (Z01)
Project #
1Z01ES023006-02
Application #
5202154
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
2
Fiscal Year
1995
Total Cost
Indirect Cost
City
State
Country
United States
Zip Code
Anna, Colleen H; Iida, Mari; Sills, Robert C et al. (2003) Expression of potential beta-catenin targets, cyclin D1, c-Jun, c-Myc, E-cadherin, and EGFR in chemically induced hepatocellular neoplasms from B6C3F1 mice. Toxicol Appl Pharmacol 190:135-45
Iida, Mari; Anna, Colleen H; Hartis, Jennifer et al. (2003) Changes in global gene and protein expression during early mouse liver carcinogenesis induced by non-genotoxic model carcinogens oxazepam and Wyeth-14,643. Carcinogenesis 24:757-70
Tam, Andrew S; Devereux, Theodora R; Patel, Arti C et al. (2003) Perturbations of the Ink4a/Arf gene locus in aflatoxin B1-induced mouse lung tumors. Carcinogenesis 24:121-32
Devereux, Theodora R; Holliday, Wanda; Anna, Colleen et al. (2002) Map kinase activation correlates with K-ras mutation and loss of heterozygosity on chromosome 6 in alveolar bronchiolar carcinomas from B6C3F1 mice exposed to vanadium pentoxide for 2 years. Carcinogenesis 23:1737-43
Herzog, Christopher R; Devereux, Theodora R; Pittman, Brian et al. (2002) Carcinogenic induction directs the selection of allelic losses in mouse lung tumorigenesis. Cancer Res 62:6424-9
Zhang, Z; Wang, Y; Vikis, H G et al. (2001) Wildtype Kras2 can inhibit lung carcinogenesis in mice. Nat Genet 29:25-33
Devereux, T R; Stern, M C; Flake, G P et al. (2001) CTNNB1 mutations and beta-catenin protein accumulation in human hepatocellular carcinomas associated with high exposure to aflatoxin B1. Mol Carcinog 31:68-73
Mingchao; Devereux, T R; Stockton, P et al. (2001) Loss of E-cadherin expression in gastric intestinal metaplasia and later stage p53 altered expression in gastric carcinogenesis. Exp Toxicol Pathol 53:237-46
Sills, R C; Hong, H L; Boorman, G A et al. (2001) Point mutations of K-ras and H-ras genes in forestomach neoplasms from control B6C3F1 mice and following exposure to 1,3-butadiene, isoprene or chloroprene for up to 2-years. Chem Biol Interact 135-136:373-86
Hayashi, S; Hong, H H; Toyoda, K et al. (2001) High frequency of ras mutations in forestomach and lung tumors of B6C3F1 mice exposed to 1-amino-2,4-dibromoanthraquinone for 2 years. Toxicol Pathol 29:422-9

Showing the most recent 10 out of 20 publications